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Özet
Amaç: Çalışmalar göstermiştir ki, vaskülogenezis ve angiogenezisin gelişme-
sinde nitric oksit ve vasküler endotelyal growth factor önemli biyolojik etkile-
re sahiptir. Gereç ve Yöntem: Bu çalışmada spesifik beyaz fertilize olmuş leg-
horin tipi yumurtalar kullanıldı. Üç başlıca alt grub dizayn edildi (kuluçkanın 
48, 72 ve 80 saatlik zaman  aralıklarında). Bulgular: 48 saatlik embriyoda, an-
jioblastlar göründü, ama olgunlaşmış endotelyal yapı mevcut değildi. 72 sa-
atlik embriyoda, endotelyal olgunlaşma başlamıştı. 80 saatlik embriyoda, ol-
dukça yüksek seviyede endotelyal olgunlaşma mevcuttu. 48 saatlik grupta, 
doku nitrit-nitrat konsantrasyonları yüksekti; ama 72 saatlik grupta bu de-
ğerler bir önceki gruptan daha yüksekti. 80 saatlik grupta,  nitrit-nitrat kon-
santrasyonları düşüktü ve 48 ve 72 saatlik gruplarla  karşılaştırıldığı zaman 
istatiksel olarak önemli idi. Sonuç: Nitrik oksidin vaskülogenezis ve angioge-
nezisin erken döneminde etkili olduğu göründü, ama bu etki zamanla azaldı. 
Anahtar Kelimeler
Angiogenezis; Vaskulogenezis; Nitrik Oxid; Vaskülar Endotelyal Growth Fak-
tor
Abstract
Aim: Studies have depicted  that nitric oxide and vascular endothelial growth 
factor  systems  have  important  biological  effects  in  the  development  of 
vasculogenesis and angiogenesis. Material and Method: In this study; specific 
pathogen free white Leghorin type fertilised eggs were used. Result: Three 
main subgroups were designed regarding time points of 48; 72 and 80 hours 
of incubation. In 48 hours old embryos anjioblasts were seen; but no mature 
endothelial  structure  was  present.  In  72  hours  old  embryos  endothelial 
maturation began.  In the 80 hours there was a high level of endothelial 
maturation. In all 48 hours groups; tissue nitrite-nitrate concentrations were 
high but in the 72 hours group these values were higher than in the first 
group. In the 80 hours group; concentrations were lower and were statistically 
significant when compared to the 48 and 72 hours groups. Discussion: NO 
seems to be effective in early phases of vasculogenesis and angiogenesis; 
but its effect decreases with time. 
Keywords
Angiogenesis; Vasculogenesis; Nitric Oxide; Vascular Endothelial Growth Fac-
tor
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Introduction
Vascular  endothelial  growth  factor  (VEGF);  secreted  by  vas-
cular tissue and a variety of tumour cells; is a potent angio-
genic factor and plays a significant role in both physiological 
and pathological angiogenesis[1-6]. Also; nitric oxide (NO) has 
tremendous effects on all tissues and is known to mediate an-
giogenesis and vascular permeability[1-6]. NO appears to play a 
key role in the VEGF-induced proliferation of endothelial cells[4].
VEGF is highly expressed in cerebral vascular malformations 
and excessive VEGF expression can induce increase vascular 
remodeling and hemorrhage[2]; NO is a product of the conver-
sion of L-arginin to citrulline; which is catalysed by nitric ox-
ide synthase (NOS)[4]. There are three isoforms of nitric oxide 
synthase (NOS): neuronal NOS (nNOS); inducible NOS (iNOS); 
and endothelial NOS (eNOS) [3]. VEGF stimulates NO release 
mediated by the VEGF receptors in human trophoblasts and also 
induces eNOS and iNOS expression in vascular endothelial cells 
in vitro[3-4]; but the inhibition of these receptors was found to 
result in increased cell proliferation; suggesting that NO may 
limit the proliferation of trophoblasts[4]. However; the inhibition 
of in vivo NO results in a decrease in angiogenesis and vascular 
permeability induced by VEGF [3]. However; the exact role of NO 
is controversial in cerebral angiogenesis and its mechanism is 
not clearly understood. 
In neurosurgery; pathological states like arteriovenous malfor-
mations; cavernous angiomas; venous angiomas and tumours 
are common diseases that a neurosurgeon often observes in 
daily practice. If the vascular development of these lesions could 
be explained; more appropriate therapeutic attempts might be 
established. We hypothesized that; NO is a critical mediator in 
VEGF activated angiogenesis in the brain. The aim of this study 
is to investigate the role of NO and VEGF systems in the physi-
ology of cerebral vasculogenesis and angiogenesis procedure in 
a chick embryo model.
Material and Method
Experimental Design and embryo collection:
In this study; we used 120 specific pathogen free (SSPF) white 
Leghorin type fertilised eggs. These eggs were provided by the 
State Chick Research Centre; Manisa; Turkey and incubated at 
37;8  0;2 C; at 65- 75 % humidity up to 48 (group 1); 72 (group 
2) and 80 hours (group 3). 
48; 72 and 80 hours incubated embriyos were evaluated with 
proper microdissection. In each time point; 10 embryos were 
collected for iNOS; eNOS and VEGF immunoreactive staining. 
In brain nitrite-nitrate assay group; early brain structures were 
dissected under 5X visual magnification and nitrite-nitrate tis-
sue concentrations were determined with Greiss method (n: 10 
for each time point). 
Histological evaluation:
Eggs were opened after 48; 72 or 80 hours of culture time; em-
bryos were dissected and fixed in formalin solution for 24 hours. 
Embryonal development was assessed regarding the Hamburg-
er-Hamilton scale under light microscope[7]. They were washed 
and soaked in graded series of ethanol and embedded in par-
affin. Transverse serial selections (5 microns thick) were taken 
from optic tectum layer of the cranium and prepared for both 
histochemical and immunohistochemical staining. Hematoxylin 
staining was used for histological observations of developmen-
tal stages of vascular endothelium. Slides were mounted using 
entellan and covered with glass coverslips prior to viewing and 
photography under the Olympus BX-40 light microscopy. 
For  immunohistochemical  staining;  sections  were  first  incu-
bated at 60°C overnight and then incubated in xylene for 30 
min. After washing with a decreasing series of ethanol; sections 
were washed with distilled water and phosphate-buffered saline 
(PBS) for 10 min. Sections were then treated with 2% trypsin 
in Tris buffer (50 mM Tris base and 150 mM NaCl dissolved 
in deionized water) at 37°C for 15 min and washed with PBS. 
Sections were drawn delineated with Dako pen (Dako; Glostrup; 
Denmark) and incubated a solution of 3% H2O2 for 15 min 
to inhibit endogenous peroxidase activity. Then sections were 
washed with PBS and incubated for 18 h at +4°C with primary 
antibodies to polyclonal anti-iNOS in a 1/100 dilution (Zymed 
61-770 South San Francisco; CA; USA); anti-eNOS in a 1/200 
solution (Biomol S-258; Hamburg; Germany) and a monoclonal 
anti-VEGF  antibody  in  1/200  dilution  (Neomarkers;  Fremont; 
CA; USA). Afterwards; sections were washed 3 times for 5 min 
each with PBS; followed by incubation with biotnylated IgG and 
then with streptavidin-peroxidase conjugate (Dako). All incuba-
tion steps were separated by 3 washing steps. After washing 
3 times for 5 min with PBS; sections were incubated with DAB 
substrate containing diaminobenzidine (Dako) 5 min to stain 
immunolabelling and then with Mayer’s hematoxylin. Sections 
were covered with mounting medium and were analysed light 
microscopically with a BX 40 microscope (Olympus; Tokyo; Ja-
pan). Control samples were processed in an identical manner 
but the primary antibody was omited. Two observers blinded to 
experimental information evaluated the staining scores inde-
pendently. Staining intensity was graded as mild (+); moderate 
(++) and strong (+++) respectively. 
Biochemical evaluation:
In all groups (n:10 for each time point); each early brain structure 
was dissected under 5X visual magnification with microsurgical 
technique and placed into glass tubes; labelled and stored in a 
deep freeze (-80 0C) until homogenization processing. Tissues 
were homogenized on ice at 12000 rpm for 3 minutes using a 
homogenizator (IKA T25 basic U.K.) in ice cold phosphate buffer 
(0;01 M; pH=7.0). Since plasma nitrite (NO2-) and nitrate (NO3-) 
levels can be used to estimate NO production; we measured the 
concentrations of these stable NO oxidative metabolites. Deter-
mination of NO2- and NO3- was based on the Griess reaction 
in which a cromophore with a strong absorbance at 545 nm 
is formed by reaction of NO2- with a mixture of naphthleth-
ylenediamine and sulfanilamide[8]. After samples were depro-
teinized with Somogyi reagent[9]; an aliquot of the sample was 
mixed with fresh reagent. 40 minutes after incubation time the 
absorbance was measured in a spectrophotometer (Shimadzu 
UV-1201; Japan) to give the NO2- concentration. A second ali-
quot was treated with copper-coated cadmium granules (Cd) 
in glycine buffer at pH 9.7 (2;5-3 g Cd granules for a 4 mL re-
action mixture) to reduce NO3- to NO2-. The concentration of 
NO2- in this aliquot thus gave the total NO3- plus NO2-; finally 
representing total NO concentration. A standard curve was es-
tablished with a set of serial dilutions (100 µmol/L to 5 µmol/L) 
of sodium nitrite. The resulting equation was then used to cal-
culate the unknown sample concentrations. 
The nitrite-nitrate data are expressed as the mean  standard 
deviation and were analysed by Anova-Varyans test. When there 
were  differences  between  groups;  Duncan  test  was  used  to 
definite whether there were difference between groups accord-
ing to time period (48; 72 and 80 hours). A probability value of 
<0.05 was considered statistically significant. 
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Results 
Group 1 (48 hours time point [Human 3;5- 4 weeks]):
In hematoxylin stained sections; the development and closure of 
neural tubes were complete. The development of brain vesicles; 
optic vesicle; paraaxial mesodermal and cardiac cells was also 
detected. In the neck and cranial areas of the body; angioblasts 
were determined but no vascular or endothelial structure had 
developed (Figure 1a). iNOS immunoreactivity was negative in 
the whole embryo and in immature neural tissue (Figure 1b); 
but in a few angioblasts; mild immunoreactivity of eNOS was 
detected (Figure 1c). Consequently; VEGF immunoreactivity was 
observed  strongly;  mainly  surrounding  matrix  of  angioblasts 
(Figure  1d).  The  result  of  nitrite-nitrate  measurement  was 
6;160;31 micromol/ tissue weight [per gram] (Diagram 1).
Group 2 (72 hours time point (Human 6 weeks)):
In hematoxylin stained sections; the development of brain ves-
icles was complete; optic vesicle differentiation continued and 
the major parts of eye differentiation were almost done. Cardi-
ac atrium and ventricles were differentiated; and red blood cells 
could be seen in these structures. Arteriolar development was 
completed and endothel formation was almost finished (Figure 
2a). While iNOS immunureactivity was still absent in the whole 
section (Figure 2b); eNOS reactivity was strongly positive; es-
pecially in endothelial layer and periarterial mesenchymal tis-
sue (Figure 2c). VEGF reactivity was still strong; especially in 
endothelial and surrounding tissue (Figure 2d). The result of 
nitrite-nitrate measurement was 5;97 0;89 micromol/ tissue 
weight (per gram) (Diagram 1) . This value was no meaningful 
statistically compared to group 1 ( p <0.05); but this value was 
Table1.  The results of descriptive statistics and comparison for N-Nitrat ngr/pgm
 
  N  Mean  Std. Deviation  Minimum  Maximum  p.
48 Hours  10  6;1610 a  ;49637  5;17  6;71 
72 Hours  10  5;9740 a  ;65104  4;95  6;86 
80 Hours  10  ;7800 b  ;17544  ;56  1;02 
Total  30  4;3050  2;57888  ;56  6;86
 
There were significant differences statistically between group 3 and other groups  (p<0;05).
Difference between group 1 and group 2 was no meaningful (p>0.05) .
0;001
Diagram 1. Chick embryo cerebral tissue nitrite- nitrate concentration values re-
garding time points (micromol/tissue weight/per gram) (meanSD).
Figure 1. Histochemical and immunohistochemical observation of chick embryo 
from 48 hours time point. Hemotoxylin staining of sections depicting vascular de-
velopment in 48 hours time point (N: Notochord; *: Paraaxial mesoderma)(A). iNOS 
immunostaining of cerebral tissue in 48 hours depicting low staining especially 
around endothelium and surrounding parenchymal tissue(B). eNOS immunostain-
ing of cerebral tissue in 48 hours depicting high activity especially around endo-
thelium and surrounding parenchymal tissue (arrow) (C). VEGF immunostaining of 
cerebral tissue in 48 hours depicting high activity especially around endothelium 
and surrounding parenchymal tissue (D).
Figure 2. Histochemical and immunohistochemical observation of chick embryo 
from 72 hours time point. Hemotoxylin staining of sections depicting vascular 
development in 72 hours time point (B: Brain) (A). iNOS immunostaining of ce-
rebral tissue in 72 hours depicting low staining especially around endothelium 
and surrounding parenchymal tissue (B). eNOS immunostaining of cerebral tissue 
in 72 hours depicting high activity especially around endothelium and surround-
ing parenchymal tissue (arrow) (C). VEGF immunostaining of cerebral tissue in 
72 hours depicting high activity especially around endothelium and surrounding 
parenchymal tissue (D).
Figure 3. Histochemical and immunohistochemical observation of chick embryo 
from  80  hours  time  point.  Hemotoxylin  staining  of  sections  depicting  vascular 
development in 80 hours time point (A). iNOS immunostaining of cerebral tissue 
in 80 hours depicting low staining especially around endothelium and surround-
ing parenchymal tissue (B). eNOS immunostaining of cerebral tissue in 80 hours 
depicting high activity especially around endothelium and surrounding parenchymal 
tissue (arrow) (C). VEGF immunostaining of cerebral tissue in 80 hours depicting 
high activity especially around endothelium and surrounding parenchymal tissue (D).
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slightly low (Table 1).
Group 3 (80 hours time point (Human 8- 10 weeks):
In this time point; the development of optic vesicles was com-
pleted. Arteriolar development was also finished and a signifi-
cant amount of vascular tissues containing endothelium was 
observed (Figure 3a). eNOS immunoreactivity was decreased to 
moderate level in all embryonic tissues at this stage; it could 
still be seen in endothelial layer; but periarteriolar activity was 
suppressed (Figure 3c). iNOS activity was still negative (Figure 
3b). Although VEGF activity was decreased minimally; it was 
still strongly positive in this stage especially in endothelial layer 
and periarteriolar mesenchymal tissue (Picture 3d). The result 
of nitrite-nitrate measurement was 0;78 0;28 micromol/ tissue 
weight (per gram) (Diagram 1). This result was lower than those 
of group 1 and 2. There were significant statistical differences 
when this value was compared to group 1 and group 2 (p<0.05) 
(Table 1). 
 
Discussion
Angiogenesis is the major key factor for growth of new tissues; 
but factors that contribute angiogenesis are still unclear. It has 
been shown that VEGF has important effects in angiogenesis 
and vasculogenesis via its R1 and R2 receptors[10]. It has been 
also suggested that depletion of VEGF in angioblasts causes 
inadequate  vasculogenesis[11].  Based  on  literature;  however; 
findings are conflicting with respect to the exact role of NO 
in angiogenesis. An increased level of NO has been found in 
human  tumors[6].  Blocking  NOS  activity  has  been  shown  to 
retard the growth of tumors; excessive production of NO in-
creases tumor growth[6]. Many conflicts about the effects of 
NO on vasculogenesis and angiogenesis have been seen for a 
few years. Jadeski et al.[12]  reported that inhibition of NOS 
by L-nitroarginine methyl ester (L-NAME) depressed neovas-
cularisation  inducted  by  a  rat’s  mamillary  tumour.  Murohara 
et. al.[13] showed that in Albino Guinea pigs; L-NAME (20 mg/
kg) inhibited the most important part of vasculogenesis and 
the increase of vascular permeability by a VEGF pathway. In a 
study by Kang et al.[14] ; inhibition of NO by L-NAME was also 
diminished. neovascularisation in a sick rat’s kidney model. In 
addition; application of L-NAME prior to VEGF caused an in-
hibition of vascular permeability[15]. Inhibition of NO system 
was also decreased angiogenesis in a rat’ and a rabit’s cornea 
models[16]. Papapetropoulos suggests that vascular prolifera-
tion induced by VEGF has been mediated by NO and could be 
blocked by L-NAME; in human umbilical venous cell culture[17]. 
It was suggested that VEGF also caused new vascularisation 
via  NO  system  and  these  effects  could  be  diminished  by  L-
NAME[18-20]. In contrast to these authors; some reports sug-
gest that NO could not affect vasculogenesis and angiogenesis 
procedure. For example; Norrby et al.[11]  noted that NO system 
inhibition by L-NAME did not inhibit angiogenesis mediated by 
VEGF165. For this reason Pipili-Synetos et al.[21-22] suggested 
in two different studies that inhibition of NO system had in-
creased angiogenesis in a chick embryo’s chorioallantoic mem-
brane model. The mechanism of the effects of NO is not clearly 
understood yet. 
In  this  study  we  want  to  evaluate  the  relationship  between 
physiological development and VEGF-NO system of chick em-
bryo  cerebral  vascular  structure.  In  the  current  study;  VEGF 
could be seen in all stages of vasculogenesis and angiogenesis. 
Although iNOS activity was not positive in all phases in physi-
ological condition; eNOS activity was strongly positive in early 
stages and it was decreased in later phases. 
Some questions still need consideration. For example; do the 
immunoreactivity  of  NOS  and  VEGF  system  really  resemble 
function al angiogenesis and vasculogenesis? Or; does iNOS 
system have any effect on vasculogenesis and angiogenesis? 
We believe that the answer to the first question was given by 
the measurement of embryonic cerebral tissue nitrite-nitrate 
values. In the literature we were not able to find any knowledge 
about concentrations of nitrite and nitrate levels of embryonic 
cranial tissues on this experimental protocol. 
Nitrite-nitrate values were high especially at the 48 hours time 
point. Levels then minimally decreased in 72 hours and dramati-
cally decreased when the 80 hours time point was reached. There 
was no statistically meaningful difference between 48 and 72 
hours groups values; but the 80 hours group values showed sta-
tistically meaningful difference in comparison to the 48 and 72 
hours groups values (p<0.05). These results may be an indicator 
for the effect of NO system and they may be confirmed with the 
immunohistochemical result. The answer to the second question 
is clearer. Tissue ichemia initiates angiogenesis procedure and 
this causes VEGF expression from endothelial cells. Then; gap 
junctions of endothelial cell line become more loose. This local 
reaction causes increased permeability. A little gap opens and 
endothelial cells  migrate from this gap. Then; the proliferation 
of these cells form a primary skeleton of a vessel. In this proce-
dure we can be suggest that iNOS activation from parenchyma 
of the brain plays a role in this step of the procedure. But re-
garding our results; it seems that iNOS activation has no effect 
during the vasculogenesis and angiogenesis procedures. Also; 
VEGF values were higher when eNOS values were high. But with 
time; eNOS activity decreased as well as VEGF values. This situ-
ation was evident especially at 72 and 80 hours time points.
It can be estimated that in vasculogenesis procedure; VEGF and 
eNOS activity have great importance and work together during 
brain vasculogenesis. But as the time passes when vasculogen-
esis is over and angiogenesis starts; many other factors may be 
involved in this procedure and the effect of NO decreases. And 
another important point is that the vasculogenesis and angio-
genesis procedures are realized by primary canalisation con-
ducted by endothelial function in cooperation with VEGF- NO 
system. In our study; a significant correlation between eNOS 
and VEGF was found in angiogenesis; suggesting that there may 
be a direct relationship between the presence of NO and VEGF 
in the regulation of angiogenesis. In previous studies; however; 
iNOS was found to be high and excessive NO production medi-
ated by iNOS has been implicated in the pathogenesis of vari-
ous diseases[6]. They hypothesized that enhanced iNOS produc-
tion supports the role of NO as a mediator of physiological and 
pathological processes[6]. Moreover; it may be speculated that 
the presence of iNOS in cerebral malformations reflects an in-
creased production of NO[6]. However; from the current data; it 
is not possible to elucidate the exact role of NO in the regula-
tion of cerebral angiogenesis. We view the presence of eNOS 
in cerebral angiogenesis as a reactive process. In future more 
studies will be needed to evaluate the exact mechanism of the 
signalling pathway regarding the vasculogenesis and angiogen-
esis procedure. In our study; we found that in the early stages 
of procedure [48 and 72 hours]; iNOS immunoreactivity was low 
whereas eNOS and VEGF reactivities were high. In 80 hours; 
eNOS and VEGF immunureactivities started to decrease. iNOS 
reactivity was absent. It seems that VEGF and eNOS activities 
initiate the procedure and then decrease. iNOS showed no ac-
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tivity during all phases. 
In conclusion; NO and VEGF seems to be effective in early phas-
es of vasculogenesis and angiogenesis. VEGF may contribute to 
angiogenesis and eNOS probably play an important role. 
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